Mcgarrybowen Wins Viagra | Adweek Mcgarrybowen Wins Viagra | Adweek
Advertisement

Mcgarrybowen Wins Viagra

Advertisement

NEW YORK Dentsu's Mcgarrybowen has added the Viagra account following a review and will succeed incumbent McCann Erickson, which defended.

Pfizer today confirmed the selection of the New York-based shop.

Last year, Pfizer spent $123 million on measured media for Viagra, and $66 million during the first seven months of 2009.

New York-based McCann, a unit of Interpublic Group, had fashioned ads for the male impotency remedy since 2004.

Viagra becomes mcgarrybowen's second Pfizer brand, after Chantix, a smoking cessation drug. The shop declined comment on Tuesday, referring queries to the client.

The male drug has become one of the world's most recognized pharmaceutical brands since its launch in April 1998. Pfizer said that U.S. sales of Viagra rose 11 percent in the first six months of the year, while global sales dropped 5 percent.
 
As Congress has increasingly focused on direct-to-consumer pharmaceutical advertising this year, erectile dysfunction drugs like Viagra have attracted attention from lawmakers who don't want TV ads to air between 6 a.m. and 10 p.m. Rep. James P. Moran (D-Va.) sponsored a House bill that would ban prime-time ads for prescription sexual aids like Viagra, citing decency grounds.

See also: "Mcgarrybowen Adds Crystal Light"